Assenagon Asset Management
PVLA

Assenagon Asset Management’s Palvella Therapeutics PVLA Stock Holding History

Assenagon Asset Management’s Portfolio PVLA Stock Details PVLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-156
Closed -$14K – 1469
2022
Q3 		$14K Sell
156
-14,935
-99% -$1.93M ﹤0.01% 1319
2022
Q2 		$2.26M Sell
15,091
-12
-0.1% -$2.19K 0.01% 794
2022
Q1 		$3.66M Sell
15,103
-3,344
-18% -$879K 0.01% 619
2021
Q4 		$5.58M Buy
18,447
+14,419
+358% +$4.62M 0.02% 483
2021
Q3 		$1.67M Buy
4,028
+298
+8% +$104K 0.01% 756
2021
Q2 		$1.14M Sell
3,730
-6,397
-63% -$1.4M ﹤0.01% 890
2021
Q1 		$2.08M Buy
10,127
+1,603
+19% +$350K 0.01% 704
2020
Q4 		$1.71M Buy
8,524
+49
+0.6% +$10.2K 0.01% 567
2020
Q3 		$1.4M Buy
8,475
+2,131
+34% +$485K 0.01% 676
2020
Q2 		$1.57M Buy
+6,344
New +$1.48M 0.01% 668
2019
Q2 		– Sell
-5,097
Closed -$1.37M – 1191
2019
Q1 		$1.37M Sell
5,097
-4,522
-47% -$1.07M 0.01% 609
2018
Q4 		$2.05M Buy
9,619
+7,816
+433% +$2.42M 0.02% 439
2018
Q3 		$808K Sell
1,803
-500
-22% -$217K 0.01% 668
2018
Q2 		$934K Buy
+2,303
New +$1.1M 0.01% 381

Other funds holding PVLA

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Assenagon Asset Management's PVLA Position: Q4 2022 in Review

Assenagon Asset Management sold out of Palvella Therapeutics (PVLA) in Q4 2022, closing a stake of 156 shares — an estimated $14K sold.

Assenagon Asset Management first reported a position in PVLA in Q2 2018 and held it in 14 quarters. The position peaked at $5.58M in Q4 2021. 63 funds tracked by Wall St. Rank hold PVLA as of Q4 2022.

  • Assenagon Asset Management reported no remaining Palvella Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Assenagon Asset Management sold 156 Palvella Therapeutics shares in Q4 2022, an estimated $14K.
  • Assenagon Asset Management first reported a position in Palvella Therapeutics in Q2 2018 and held it in 14 quarters.
  • Assenagon Asset Management's Palvella Therapeutics position peaked at $5.58M in Q4 2021.
  • 63 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q4 2022.

Based on Assenagon Asset Management's 13F filing for Q4 2022, filed 12 Jan 2023.